Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher tous les synonymes
Human Polyclonal PPP1R13B Primary Antibody pour IF (p), IHC (p) - ABIN674379
Xie, Yang, Chi, Yang, Wang, Xu: Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study. dans Chinese journal of cancer 2017
Human Polyclonal PPP1R13B Primary Antibody pour IHC, ELISA - ABIN1584021
Matsumoto, Weckbecker, Cory: Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells. dans Cancer communications 1990
Show all 2 Pubmed References
After genotoxic stress, Aspp1 promotes hematopoietic stem cell (HSC (Montrer FUT1 Anticorps)) cycling and induces p53 (Montrer TP53 Anticorps)-dependent apoptosis in cells with persistent DNA damage foci. Aspp1 also attenuates HSC (Montrer FUT1 Anticorps) self-renewal and accumulation of DNA damage in p53 (Montrer TP53 Anticorps) null HSCs.
Our study demonstrates a novel role for ASPP1 and ASPP2 (Montrer TP53BP2 Anticorps) in the death of retinal ganglion cells.
Aspp1 plays a crucial role in the initial assembly and function of lymphatic vessels during mouse development in a p53 (Montrer TP53 Anticorps)-independent manner.
results provide new insights into EGR-1 (Montrer EGR1 Anticorps)/ASPP1 regulatory loop in sensitizing Quercetin-induced apoptosis. EGR-1 (Montrer EGR1 Anticorps)/ASPP1, therefore, may be potentially used as therapeutic targets to improve cancer's response to pro-apoptosis treatments.
Results showed that the protein expression levels of ASPP1 in esophageal squamous cell carcinoma (ESCC) tissues and in paired noncancerous tissues were similar but was significantly associated with histological differentiation and invasive depth which suggest that it might be involved in the progression of ESCC.
Increased expression of p53 (Montrer TP53 Anticorps) and ASPP1 and downregulation of iASPP (Montrer PPP1R13L Anticorps).
ASPP1/2-PP1 complexes are required for chromosome segregation and kinetochore-microtubule attachments.
ASPP1/2 interacted with centrosome linker protein (Montrer LAT Anticorps) C (Montrer PROC Anticorps)-Nap1 (Montrer CEP250 Anticorps). Co-depletion of ASPP1 and ASPP2 (Montrer TP53BP2 Anticorps) inhibited re-association of C-Nap1 (Montrer CEP250 Anticorps) with centrosome at the end of mitosis.
ASPP1 and ASPP2 (Montrer TP53BP2 Anticorps) cooperate with oncogenic RAS to enhance the transcription and apoptotic function of p53 (Montrer TP53 Anticorps).
When the Px(T)PxR (Montrer NR1I2 Anticorps) motif is deleted or mutated via insertion of a phosphorylation site mimic (T311D), PP-1c fails to bind to all three ASPP proteins, ASPP1, ASPP2 (Montrer TP53BP2 Anticorps) and iASPP (Montrer PPP1R13L Anticorps).
the mRNA expression of ASPP1 and ASPP2 (Montrer TP53BP2 Anticorps) was frequently dowregulated in tumor tissues, and this decreased significantly in samples expressing wild-type p53 (Montrer TP53 Anticorps)
ASPP1 promoter methylation may be associated with the malignant progression of non-small cell lung cancer, and ASPP1 expression promotes cellular apoptosis.
The ability of ASPP1 to activate YAP (Montrer YAP1 Anticorps) results in the decreased expression of LATS2, which lowers the ability of p53 (Montrer TP53 Anticorps) to induce p21 (Montrer CDKN1A Anticorps), cell-cycle arrest and senescence.
This gene encodes a member of the ASPP (apoptosis-stimulating protein of p53) family of p53 interacting proteins. The protein contains four ankyrin repeats and an SH3 domain involved in protein-protein interactions. ASPP proteins are required for the induction of apoptosis by p53-family proteins. They promote DNA binding and transactivation of p53-family proteins on the promoters of proapoptotic genes. Expression of this gene is regulated by the E2F transcription factor.
protein phosphatase type 2C alpha 1
, protein phosphatase 1, regulatory (inhibitor) subunit 13B
, apoptosis-stimulating protein of p53, 1
, apoptosis-stimulating of p53 protein 1-like
, apoptosis-stimulating of p53 protein 1
, protein phosphatase 1 regulatory subunit 13B
, transformation related protein 53 binding protein 2
, tumor protein p53 binding protein, 2
, tumor protein p53-binding protein, 2
, apoptosis-stimulating protein of p53